Pharmacology of Psychiatric Drugs and Their Effects on Sleep

  • Sue WilsonEmail author


This chapter provides an overview of psychotropic drugs encountered in psychiatry and includes the effects on sleep of those frequently prescribed for depression, anxiety, psychosis, dementia and ADHD, with a small section about recreational drugs. Drugs which treat, exacerbate or provoke sleep disorders are covered in the last section.


  1. Bell C, Vanderlinden H, Hiersemenzel R, Otoul C, Nutt D, Wilson S. The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy. J Sleep Res. 2002;11:255–63.CrossRefPubMedGoogle Scholar
  2. Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response inpatients with major depressive disorder. J Clin Psychopharmacol. 2006;26:75–8.CrossRefPubMedGoogle Scholar
  3. Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol. 2009;23:249–57.CrossRefPubMedGoogle Scholar
  4. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59:1052–60.CrossRefPubMedGoogle Scholar
  5. Feige B, Voderholzer U, Riemann D, Dittmann R, Hohagen F, Berger M. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology. 2002;26:246–58.CrossRefPubMedGoogle Scholar
  6. Feige B, Gann H, Brueck R, Hornyak M, Litsch S, Hohagen F, Riemann D. Effects of alcohol on polysomnographically recorded sleep in healthy subjects. Alcohol Clin Exp Res. 2006;30:1527–37.CrossRefPubMedGoogle Scholar
  7. Friston KJ, Sharpley AL, Solomon RA, Cowen PJ. Lithium increases slow wave sleep: possible mediation by brain 5-HT-2 receptors. Psychopharmacology. 1989;98:139–40.CrossRefPubMedGoogle Scholar
  8. Gann H, Riemann D, Hohagen F, Muller WE, Berger M. The influence of carbamazepine on sleep-EEG and the clonidine test in healthy subjects: results of a preliminary study. Soc Biol Psychiatry. 1994;35:893–6.CrossRefGoogle Scholar
  9. Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, Miceli J, Knapp L, Allen RP. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. Sleep. 2014;37:635–43.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gossop M, Bradley B. Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electrostimulation. Drug Alcohol Dep. 1984;13:191–8.CrossRefGoogle Scholar
  11. Gouzoulis E, Steiger A, Ensslin M, Kovar A, Hermle L. Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; “eve”) in healthy volunteers. Biol Psychiatry. 1992;32:1108–17.CrossRefPubMedGoogle Scholar
  12. Harding GFA, Alford CA, Powell TE. The effects of sodium valproate on sleep, reaction times, and visual evoked potential in normal subjects. Epilepsia. 1985;26:597–601.CrossRefPubMedGoogle Scholar
  13. Jain SV, Glauser TA. Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia. 2014;55:26–37.CrossRefPubMedGoogle Scholar
  14. Kaynak H, Kaynak D, Gozukirmizi E, et al. The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med. 2004;5:15–20.CrossRefPubMedGoogle Scholar
  15. Landolt HP, Raimo EB, Schnierow BJ, Kelsoe JR, Rapaport MH, Gillin JC. Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatry. 2001;58:268–76.CrossRefPubMedGoogle Scholar
  16. Landolt HP, Kelsoe JR, Rapaport MH, Gillin JC. Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. J Sleep Res. 2003;12:13–8.CrossRefPubMedGoogle Scholar
  17. Larrosa O, de la Llave Y, Bario S, Granizo JJ, Garcia-Borreguero D. Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study. Sleep. 2001;24:282–5.CrossRefPubMedGoogle Scholar
  18. Larsson V, Aarsland D, Ballard C, Minthon L, Londos E. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia. Int J Geriatr Psychiatry. 2010;25:1030–8.CrossRefPubMedGoogle Scholar
  19. Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol. 2010;37:2156–66.CrossRefPubMedGoogle Scholar
  20. Monaca C, Boutrel B, Hen R, Hamon M, Adrien J. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology. 2003;28:850–6.CrossRefPubMedGoogle Scholar
  21. Monti JM, Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev. 2004;8:133–48.CrossRefPubMedGoogle Scholar
  22. Mouret J, Lemoine P, Minuit MP, Benkalfat C, Renardet M. Effects of trazodone on the sleep of depressed patients. Psychopharmacology. 1988;95:S37–43.CrossRefPubMedGoogle Scholar
  23. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305–13.CrossRefPubMedGoogle Scholar
  24. Nutt DJ. Death by tricyclic: the real antidepressant scandal? J Psychopharmacol. 2005;19(2):123–4.CrossRefPubMedGoogle Scholar
  25. Paterson LM, Wilson SJ, Nutt DJ, Hutson PH, Wilson SJ. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacology. 2007;191:943–50.CrossRefPubMedGoogle Scholar
  26. Paterson LM, Nutt DJ, Durant C, Wilson SJ. Efficacy of trazodone in primary insomnia: a double-blind randomised placebo-controlled polysomnographic study. J Psychopharmacol. 2009;23:A32.Google Scholar
  27. Plazzi G, Pizza F, Vandi S, Arico D, Bruni O, Dauvilliers Y, Ferri R. Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy. Sleep Med. 2014;15:1046–54.CrossRefPubMedGoogle Scholar
  28. Riemann D, Gann H, Dressing H, Muller WE, Aldenhoff JB. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatry Res. 1994;51:253–67.CrossRefPubMedGoogle Scholar
  29. Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Ruther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry. 2002;35:165–74.CrossRefPubMedGoogle Scholar
  30. Russo EB, Guy GW, Robson PJ, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers. 2007;4:1729–43.CrossRefPubMedGoogle Scholar
  31. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437:1257–63.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Schredl M, Weber B, Braus D, et al. The effect of rivastigmine on sleep in elderly healthy subjects. Exp Gerontol. 2000;35:243–9.CrossRefPubMedGoogle Scholar
  33. Schredl M, Hornung O, Regen F, et al. The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled study. Pharmacopsychiatry. 2006;39:205–8.CrossRefPubMedGoogle Scholar
  34. Sharpley AL, Rawlings NB, Brain S, McTavish SF, Cowen PJ. Does agomelatine block 5-HT2C receptors in humans? Psychopharmacology. 2011;213:653–5.CrossRefPubMedGoogle Scholar
  35. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs. 2005;65:927–47.CrossRefPubMedGoogle Scholar
  36. Wilson SJ, Bailey JE, Rich AS, et al. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. J Psychopharmacol. 2005;19:609–13.CrossRefPubMedGoogle Scholar
  37. Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24:1577–601.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Brain Sciences, Centre for PsychiatryImperial College LondonLondonUK

Personalised recommendations